Nabriva Therapeutics (NASDAQ:NBRV) Earns Hold Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Free Report) in a research note released on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. Nabriva Therapeutics Trading Up 709,900.0 % Shares of NASDAQ NBRV opened at $1.42 on Thursday. The company has a current ratio of 0.85, a […]
More Stories
State Official Says No System to Identify Whether Voters Are Noncitizens
By Zachary Stieber A top Washington state official said on Oct. 29 that the state has no way to confirm...
The Great Banking Betrayal: Who Really Paid the Price?
By Stephen Zogopoulos, USNN World News USNN WORLD NEWS | SPECIAL EDITORIAL INVESTIGATION October 30, 2026 | Investigative Opinion &...
Trump Says Democratic Candidate Should Be Prosecuted Amid Alaska Same-Name Controversy
By Jack Phillips President Donald Trump has called for the prosecution of a Democratic Alaska Senate candidate amid allegations that...
Greenville Police Rule Hayden Panettiere’s Death Accidental, Close Investigation
By Kimberly Hayek The Greenville, South Carolina, police department concluded its investigation Wednesday into the death of actress Hayden Panettiere...
Acclaimed Stage Actor Patrick Stewart, and ‘Star Trek’ and ‘X-Men’ Star, Dies at Age 86
By Elma Aksalic British actor Sir Patrick Stewart, best known for his roles in the “Star Trek” franchise and “X-Men”...
Judge Narrows Defamation Lawsuit Against Candace Owens Over Claims Brigitte Macron Is Male
By Rachel Roberts A Delaware judge ruled that French President Emmanuel Macron and his wife, Brigitte, can continue their defamation...